Ajax-Loading

Merck & Company Inc - Interest Expense

Merck & Company Inc's Fiscal Year is From January To December - All Figures are in USD, Billions.

The item "Interest-Expense" stands at 1.18 Billion United States Dollars for the trailing twelve months (TTM) period ending 09/30/2025, the lowest value since 03/31/2024.

Merck & Company Inc's third quarter result of 0.238 Billion USD for the item "Interest Expense" represents a decrease of -21.97 percent compared to it's second quarter result.

Also, Merck & Company Inc's third quarter result of 0.238 Billion USD for the item "Interest Expense" represents a decrease of -27.88 percent compared to it's third quarter result of last year.

Looking again at the trailing twelve months series (TTM), Merck & Company Inc's third quarter result of 1.18 Billion USD for the item "Interest Expense" represents a decrease of -7.21 percent compared to it's second quarter result.


Regarding the One-Year-Change of the series, the current value constitutes a decrease of -5.51 percent compared to the value the year prior.
The 1 year change in percent is -5.51.
The 3 year change in percent is 26.50.
The 5 year change in percent is 40.45.
The 10 year change in percent is 77.25.

The Serie's long term average value is 0.854 Billion United States Dollars. It's latest available value, on 09/30/2025, is 38.71 percent higher, compared to it's long term average value.
The Serie's change in percent from it's minimum value, on 09/30/2015, to it's latest available value, on 09/30/2025, is +77.25%.
The Serie's change in percent from it's maximum value, on 03/31/2025, to it's latest available value, on 09/30/2025, is -7.57%.

Interest Expense for Related Companies:

LogoNameMarket Cap (USD)
LogoEli Lilly and Company - Interest Expense905,699,262,464.00
LogoJohnson & Johnson - Interest Expense486,508,953,600.00
LogoAbbVie Inc - Interest Expense399,570,305,024.00
LogoRoche Holding AG - Interest Expense317,433,206,677.55
LogoAstraZeneca PLC - Interest Expense280,205,508,085.11